16-2496681-C-T
Position:
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PM1PM2PP5_Very_Strong
The NM_001199107.2(TBC1D24):c.533C>T(p.Ser178Leu) variant causes a missense change. The variant allele was found at a frequency of 0.00000205 in 1,460,950 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Genomes: not found (cov: 33)
Exomes 𝑓: 0.0000021 ( 0 hom. )
Consequence
TBC1D24
NM_001199107.2 missense
NM_001199107.2 missense
Scores
2
11
6
Clinical Significance
Conservation
PhyloP100: 6.08
Genes affected
TBC1D24 (HGNC:29203): (TBC1 domain family member 24) This gene encodes a protein with a conserved domain, referred to as the TBC domain, characteristic of proteins which interact with GTPases. TBC domain proteins may serve as GTPase-activating proteins for a particular group of GTPases, the Rab (Ras-related proteins in brain) small GTPases which are involved in the regulation of membrane trafficking. Mutations in this gene are associated with familial infantile myoclonic epilepsy. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 12 ACMG points.
PM1
In a domain Rab-GAP TBC (size 215) in uniprot entity TBC24_HUMAN there are 17 pathogenic changes around while only 3 benign (85%) in NM_001199107.2
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 16-2496681-C-T is Pathogenic according to our data. Variant chr16-2496681-C-T is described in ClinVar as [Pathogenic]. Clinvar id is 133246.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2496681-C-T is described in Lovd as [Likely_pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TBC1D24 | NM_001199107.2 | c.533C>T | p.Ser178Leu | missense_variant | 2/8 | ENST00000646147.1 | NP_001186036.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TBC1D24 | ENST00000646147.1 | c.533C>T | p.Ser178Leu | missense_variant | 2/8 | NM_001199107.2 | ENSP00000494678.1 | |||
ENSG00000260272 | ENST00000564543.1 | c.533C>T | p.Ser178Leu | missense_variant | 1/3 | 2 | ENSP00000455547.1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 genomes
Cov.:
33
GnomAD3 exomes AF: 0.00000804 AC: 2AN: 248760Hom.: 0 AF XY: 0.0000148 AC XY: 2AN XY: 135118
GnomAD3 exomes
AF:
AC:
2
AN:
248760
Hom.:
AF XY:
AC XY:
2
AN XY:
135118
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000205 AC: 3AN: 1460950Hom.: 0 Cov.: 31 AF XY: 0.00000275 AC XY: 2AN XY: 726854
GnomAD4 exome
AF:
AC:
3
AN:
1460950
Hom.:
Cov.:
31
AF XY:
AC XY:
2
AN XY:
726854
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 33
GnomAD4 genome
Cov.:
33
ExAC
AF:
AC:
2
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:4Other:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Autosomal dominant nonsyndromic hearing loss 65 Pathogenic:2
Pathogenic, flagged submission | literature only | Division of Medical Genetics; Sainte-Justine Hospital | Dec 22, 2014 | - - |
Pathogenic, flagged submission | literature only | OMIM | Jul 01, 2014 | - - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Aug 01, 2018 | - - |
Developmental and epileptic encephalopathy, 1;C3892048:Autosomal dominant nonsyndromic hearing loss 65;CN236805:Caused by mutation in the TBC1 domain family, member 24 Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 22, 2023 | For these reasons, this variant has been classified as Pathogenic. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt TBC1D24 protein function. ClinVar contains an entry for this variant (Variation ID: 133246). This missense change has been observed in individuals with autosomal dominant non-syndromic deafness (PMID: 24729539, 24729547, 33986365). It has also been observed to segregate with disease in related individuals. This variant is present in population databases (rs483352866, gnomAD 0.002%). This sequence change replaces serine, which is neutral and polar, with leucine, which is neutral and non-polar, at codon 178 of the TBC1D24 protein (p.Ser178Leu). - |
Autosomal recessive nonsyndromic hearing loss 86 Other:1
not provided, no classification provided | literature only | Molecular Biology of Hearing and Deafness Laboratory, Xinhua Hospital | - | - - |
DOORS syndrome Other:1
not provided, no classification provided | literature only | GeneReviews | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Uncertain
D
BayesDel_noAF
Benign
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Benign
.;T;T;.;.;.;.
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Pathogenic
.;.;D;D;D;D;D
M_CAP
Uncertain
D
MetaRNN
Uncertain
D;D;D;D;D;D;D
MetaSVM
Benign
T
MutationAssessor
Uncertain
M;M;M;.;.;M;.
PrimateAI
Uncertain
T
PROVEAN
Benign
N;.;N;.;.;.;N
REVEL
Pathogenic
Sift
Benign
T;.;T;.;.;.;T
Sift4G
Uncertain
D;.;D;.;.;D;D
Polyphen
P;P;P;.;.;P;.
Vest4
MutPred
Loss of relative solvent accessibility (P = 0.3219);Loss of relative solvent accessibility (P = 0.3219);Loss of relative solvent accessibility (P = 0.3219);Loss of relative solvent accessibility (P = 0.3219);Loss of relative solvent accessibility (P = 0.3219);Loss of relative solvent accessibility (P = 0.3219);Loss of relative solvent accessibility (P = 0.3219);
MVP
MPC
0.77, 0.84
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at